Ignite Creation Date:
2025-12-24 @ 9:22 PM
Ignite Modification Date:
2026-01-24 @ 10:35 PM
Study NCT ID:
NCT02734004
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-25
First Post:
2016-03-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03-17
Start Date Type:
ACTUAL
Primary Completion Date:
2021-09-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-09-17
Completion Date Type:
ESTIMATED
First Submit Date:
2016-03-17
First Submit QC Date:
None
Study First Post Date:
2016-04-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-09-14
Results First Submit QC Date:
None
Results First Post Date:
2023-10-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-20
Last Update Post Date:
2025-11-25
Last Update Post Date Type:
ESTIMATED